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Highlights 
 A five-year prospective study of predominant polarity in 191 bipolar patients. 
 Predominant polarity was manic in 16%, intermediate in 48% and depressive in 36 %.  
 The manic polarity group had best outcome with regard to time ill.  
 The depressive polarity group had highest incidence of suicide attempts. 
 The stability of classification of predominant polarity over time was only moderate. 
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ABSTRACT 
 
Background: Patients with bipolar disorder (BD) differ in their relative predominance of types of 
episodes, yielding predominant polarity, which has important treatment implications. However, 
few prospective studies of predominant polarity exist.  
Methods: In the Jorvi Bipolar Study (JoBS), a regionally representative cohort of 191 BD I and BD 
II in- and outpatients was followed for five years using life-chart methodology. Differences 
between depressive (DP), manic (MP), and no predominant polarity (NP) groups were examined 
regarding time ill, incidence of suicide attempts, and comorbidity.  
Results: At baseline, 16% of patients had MP, 36% DP, and 48% NP. During the follow-up the MP 
group spent significantly more time euthymic, less time in major depressive episodes, and more 
time in manic states than the DP and NP groups. The MP group had significantly lower incidence 
of suicide attempts than the DP and NP group, lower prevalence of comorbid anxiety disorders 
but more psychotic symptoms lifetime and more often (hypo)manic first phase of the illness than 
the DP group. Classification of predominant polarity was influenced by the timeframe used.  
Limitations: The retrospective counting of former phases is vulnerable to recall bias. Assignment 
of dominant polarity may necessitate a sufficient number of illness phases. 
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Conclusions: Predominant polarity has predictive value in predicting group differences in course 
of illness, but individual patients’ classification may change over time. Patients with manic 
polarity may represent a more distinct subgroup than the two others regarding illness course, 
suicide attempts, and psychiatric comorbidity.  
 
Key words: Bipolar disorder, predominant polarity, outcome, suicide attempts 
Introduction  
Bipolar disorder (BD) manifests as recurrent depressive, (hypo)manic, and mixed episodes as well 
as subthreshold symptoms (Judd et al., 2002; Judd et al., 2003; Pallaskorpi et al., 2015). However, 
patients with BD differ markedly in their relative predominance of types of episodes during illness 
course. Such differences may have important implications for treatment decisions, including both 
pharmacological and non-pharmacological treatments, which differ in efficacy in treating and 
preventing mania and depression (Popovic et al., 2012; Popovic et al., 2013). The existence of 
dimensional differences within BD has long been acknowledged (Angst, 1978), but nosological 
focus has been on the lifetime worst manic syndromes and subdividing BD into types I and II or 
the soft bipolar spectrum. Only in 2006 did Colom et al. (Colom et al., 2006) introduce the first 
widely known classification of predominant polarity, based on differences in dominant types of 
illness episodes during illness history. 
The definition by Colom et al. (Colom et al., 2006) set the threshold for a patient having a specific 
predominant polarity at two-thirds of lifetime episodes being either manic or depressive. In 
previous mostly cross-sectional and retrospective studies, predominantly manic (MP) or 
depressive polarity (DP) has been present in 42.4-71.8% of BD patients (Carvalho et al., 2014). The 
varying prevalences across studies can in part be explained by differences in the definitions used. 
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Some studies have applied a less strict definition of simply having more lifetime episodes of either 
manic or depressive polarity (Daban et al., 2006; Forty et al., 2009; Gonzalez-Pinto et al., 2010), 
whereas most studies have used the definition of Colom et al. (Colom et al., 2006; Rosa et al., 
2008; Garcia-Lopez et al., 2009; Mazzarini et al., 2009; Vieta et al., 2009; Murru et al., 2011; Nivoli 
et al., 2011; Popovic et al., 2014; Belizario et al., 2018; Vidal-Rubio et al., 2018), and only a few 
both (Baldessarini and Salvatore et al.2012; Azorin et al., 2015). When defining the polarity, mixed 
episodes are excluded in most studies. Carvalho et al. (Carvalho et al., 2014) reported in their 
systematic review the median prevalences of DP and MP to be 21.4% and 26.0%, respectively. 
However, they noted that higher prevalence of MP was found in studies with only BD I patients 
and higher prevalence of DP in studies with also BD II patients. It is noteworthy that BD I patients 
dominate the literature on predominant polarity.  
The concept of predominant polarity was created to help clinicians in planning optimal treatment 
based on the expected illness course in light of the past. However, only a few prospective studies 
have thus far been conducted (Garcia-Lopez et al., 2009; Gonzalez-Pinto et al., 2010; Belizario et 
al., 2018), and the actual predictive validity of the classification remains uncertain. Furthermore, 
the predominant polarity is defined based on the ratio of illness episodes. While this is reasonable 
approximation from a clinician’s point of view, a limitation is that it does not consider the duration 
of episodes, which varies not only between but also within individuals during illness course 
(Grande et al., 2016). Thus, the total morbidity burden within and between patients is only partly 
captured by the concept of predominant polarity. Moreover, the predominant polarities could be 
regarded as a continuum between the extremes of manic and depressive polarity, with “no 
predominant polarity” (no polarity, NP) as an intermediate group (Angst, 1978; Angst, 2007; Qiu 
et al., 2017). This dimensional view of predominant polarity and the role of the intermediate no 
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polarity group has been only recently addressed in the literature (Belizario et al., 2018; Vidal-
Rubio et al., 2018).  
The predominant polarity is defined by the preceding course of BD, but it may well be associated 
with other important clinical features such as comorbid mental disorders or risk of suicide 
attempts. A history or higher number of suicide attempts (Colom et al., 2006; Gonzalez-Pinto et 
al., 2010; Baldessarini and Undurraga et al.2012; Popovic et al., 2014) has repeatedly been linked 
to DP, and moreover, when mixed states were combined with the depressive category, the 
association with suicide attempts almost doubled (Baldessarini and Undurraga et al.2012). In 
contrast, Azorin et al. (Azorin et al., 2015) found the MP group to have more suicide attempts and 
explained this by higher levels of cyclothymic and hyperthymic temperaments in MP. A 7-year 
longitudinal cohort study also found higher number of SAs in the MP group (Belizario et al., 2018). 
Some studies have reported the occurrence of anxiety disorders (Azorin et al., 2015) and DSM-IV 
axis II comorbidity (Baldessarini and Undurraga et al.2012) to be more frequent in the DP group, 
while others have not found association with (current) comorbid mental disorders and polarity 
dominance (Koyuncu et al., 2010; Murru et al., 2011; Popovic et al., 2014). However, as the current 
illness phase is known to strongly covary with the prevalence of psychiatric comorbidity both 
cross-sectionally and longitudinally (Mantere et al., 2010; Pavlova et al., 2015), the association of 
comorbid internalizing disorders with DP and externalizing disorders with MP is plausible.  
There is at present an accumulating literature on patterns of clinical correlates of predominant 
polarity (Carvalho et al., 2014; Garcia-Jimenez et al., 2017).  However, findings of these studies 
have not been fully consistent, and these associations have seldom been tested in prospective 
studies. 
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To our knowledge, no previous studies including both BD I and II patients have examined the 
predictive validity of predominant polarity in terms of time ill , and only few the incidence of 
suicide attempts or the stability of the classification in the long-term follow-up. We hypothesized 
that (a) retrospective and prospectively defined predominant polarities would be consistent; that 
(b) patients with depressive predominant polarity would spend more time depressed and (c) have 
more suicide attempts than patients with manic predominant polarity; and that (d) patients with 
manic predominant polarity would more often have suffered from lifetime comorbid substance 
abuse disorders and patients with depressive predominant polarity more often from lifetime 
comorbid anxiety disorders.   
 
Methods  
Screening and baseline evaluation 
The Jorvi Bipolar Study (JoBS) is a collaborative research project of the Department of Mental 
Health and Substance Abuse Services, National Institute of Health and Welfare, Helsinki, and the 
Department of Psychiatry, Jorvi Hospital, Espoo, Finland. The Department of Psychiatry at Jorvi 
Hospital provides secondary care psychiatric services to the catchment area’s citizens. The study 
protocol was approved by the Ethics Committee of Helsinki and Uusimaa Healthcare District. The 
methodology of JoBS has been described elsewhere in detail ( Mantere et al., 2010; Pallaskorpi et 
al., 2015).  
In brief, by using the Mood Disorder Questionnaire (MDQ) (Hirschfeld et al., 2000)(29), all 
patients in the catchment area of Jorvi Hospital with possible new DSM-IV BD episodes were 
screened. A positive screen or clinical suspicion of BD resulted in confirming the diagnosis by 
using the Structured Clinical Interview for DSM-IV Disorders (SCID-I/P) (First et al., 2002) after 
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informing the subject about the study protocol and requesting written consent. All possible 
information, such as psychiatric records, interviews with family members, and observations of 
attending personnel, was used. The final sample included 191 patients with an ongoing mood 
episode. A retrospective life-chart and psychiatric records were used to gather former illness 
history, including the number of lifetime mood episodes. Data on former and current suicidality, 
demographic characteristics, and treatment received were collected. Lifetime and current 
comorbid diagnoses were assessed by using SCID-I (First et al., 2002) and SCID-II (First et al., 
1997) interviews. Other tools used at baseline comprised the Young Mania Rating Scale (YMRS)  
(Young et al., 1978) (32), the 17-item Hamilton Depression Scale (HAM-D) (Hamilton, 1960), the 
21-item Beck Depression Inventory (BDI) (Beck et al., 1961), the Beck Anxiety Inventory (BAI) 
(Beck et al., 1988), the Beck Hopelessness Scale (HS) (Beck et al., 1974), the Scale for Suicidal 
Ideation (SSI) (Beck et al., 1979), the DSM-IV Social and Occupational Functional Assessment 
Scale (SOFAS) (Goldman et al., 1992), the Perceived Social Support Scale-Revised (Blumenthal et 
al., 1987), and the short Eysenck’s Personality Inventory (Al-Issa, 1964).  
 
Follow-up 
A detailed description of the follow-up methodology has been presented in previous reports 
(Pallaskorpi et al., 2015; Mantere et al., 2008). In interviews at 6 and 18 months and at 5 years, the 
duration and timing of major depressive, hypomanic, manic, mixed, depressive mixed, 
cyclothymic, and substance-induced phases of BD were retrospectively identified by using a life-
chart method similar, but not identical to the Longitudinal Interval Follow-up Evaluation (Keller et 
al., 1987). Using probes related to important life events, change points in the psychopathological 
states were explored to maximize the accuracy of the assessment. The definitions of DSM-IV for 
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mood episodes were used with two exceptions: (i) the minimum duration of hypomania was 2 
days instead of 4 days and (ii) the depressive mixed state was defined according to the definition 
of Benazzi and Akiskal (Benazzi and Akiskal2001) (i.e. ≥ 3 simultaneous hypomanic symptoms 
present for at least half of the time during a major depressive episode [MDE]). States of 
subsyndromal symptoms (depressive or hypomanic) were rated when neither the full criteria for 
an illness phase nor euthymia were present. At all follow-up interviews, SCID-I (First et al., 2002) 
and SCID-II (First et al., 1997)  were conducted and the forementioned scales and tools were used 
to gather information on comorbid disorders, psychosocial factors, symptom severity, and 
suicidality. Information was gathered in a graphic life-chart.  
In this study, we excluded as outliers three patients (1.6%) with reportedly more than 100 lifetime 
mood episodes by baseline because of imprecision in numbers and types of illness phases. Thus, 
188 patients (98.4%) of the original cohort of 191 were included when retrospectively defining the 
predominant polarity and analyzing the cross-sectional baseline data. The prospective follow-up 
data for mood episodes and suicide attempts were available for 175 patients (91.6%) who were 
included in the analysis of time ill and incidence of suicide attempts. The median follow-up time 
was 62.4 months and the mean number of suicide attempts 0.51 (median 0.00). The patients not 
included in the follow-up (N=16) did not differ from those who were included (N=175) in terms of 
gender (male 31.3% vs. 48.6%, p=0.184), BD type (type I 62.5% vs. 45.7%, p=0.198), lifetime 
psychotic symptoms (62.5% vs. 49.7%, p=0.327), former suicide attempts (50.0% vs. 51.4%, 
p=0.913), some lifetime anxiety disorder (56.3% vs. 53.1%, p=0.812), lifetime substance use 
disorder (56.3% vs. 50.3%, p=0.648), being inpatients at baseline (43.8% vs. 33.1%, p=0.391), or 
having depressive first episode (37.5% vs. 52.5%, p=0.248). Excluding the three outliers, the 
subjects not included in the follow-up did not differ in terms of number of earlier episodes (t=0.59, 
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p=0.556). When examining the stability of the dominant polarity categories, patients with no 
illness phases in follow-up (N=30, 17.1%) were excluded.  
 
Definition of predominant polarity 
We defined predominant polarity according to Colom et al. (Colom et al., 2006), requiring two-
thirds of the past episodes to be either (hypo)manic or depressive in order to have a dominant 
polarity. Time of the baseline interview was used as a cut-point when counting the phases 
(minimum 1, maximum 84, median 10), and the index phase was included. The distribution of 
predominant polarity groups according to different categorization is seen in Table 1. When 
conducting the analyses, we used the categorization where mixed phases were combined with 
manic and hypomanic phases, and depressive mixed phases were combined with major 
depressive episodes (MDEs) (Definition 2 in Table 1). This is in accordance with DSM-5 (American 
Psychiatric Association, 2013), which replaced the former term “mixed episode” with a mixed-
features specifier that can be applied to episodes of major depression, hypomania, or mania. 
However, we also conducted sensitivity analyses excluding the mixed phases (still including them 
in the total sum of the phases; Definition 1, Table 1). 
 
Statistical methods 
The Chi-square or Kruskall-Wallis test was used when examining the sociodemographic and 
clinical characteristics between the three polarity groups, and Kruskall-Wallis test when 
examining the differences in time spent ill. Poisson regression was used when comparing the 
incidence of suicide attempts, the number of phases, and the number of hospitalizations in the 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
11 
 
follow-up. These analyses were conducted in two ways, using first the NP group and then the DP 
group as a reference category. Multinomial logistic regression was used when comparing the 
differences in clinical variables and occurrence of comorbid disorders between the groups. 
Polychoric correlation analysis with R package “polycor” (version 0.7-9) was used to examine the 
stability of the polarity types. Polychoric correlations refer to correlations of underlying normally 
distributed liability variables as estimated from ordinal data.  Otherwise, IBM SPSS version 24 
(SPSS Inc., Chicago, IL, USA) was used. 
 
Results 
Overall, about half of all patients, 98 of 188 (52%), had a predominant polarity. In 30 patients 
(16%), the predominant polarity was manic, in 68 (36%) depressive, and in 90 (48%) no 
predominant polarity was assigned (Table 1). In the baseline sociodemographic and clinical 
characteristics, significant differences between the three groups were found in BD type, type of 
index phase, type of first illness phase, occurrence of lifetime psychotic symptoms, anxiety 
disorders, and substance abuse disorders, and outpatient versus inpatient status at intake (Table 
2). During follow-up 44.4% of the MP group, 40.5% of the NP group, and 34.8% of the DP group 
had at least one hospital admission. In Poisson regression analyses, no difference emerged in the 
number of hospitalizations during follow-up between the MP, NP, and DP groups (means 1.7, 1.2, 
and 0.7, respectively, median 0.00 for all groups) when age, gender, and BD type were adjusted. 
However, there was a tendency for patients in the MP group to have more hospital admissions 
than patients in the DP group (B=0.441, p=0.056). Furthermore, patients in the NP group were 
most often inpatients at intake (Table 1). Inpatients in the MP group were hospitalized exclusively 
for manic (88.9%) or mixed state (11.1%), in the DP group more often for MDE (71.4%) than for 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
12 
 
manic (14.2%) or mixed state (14.3%), and in the NP group more often for MDE (65.0%) than for 
manic (25.0%) or mixed state (10.0%).  
 
Predictive validity of predominant polarity in time ill and number of phases in follow-up 
The time spent in different illness states during the 5-year follow-up for the manic, depressive, 
and no polarity groups is seen in Figure 1. Within the whole sample (N=175), the three groups 
differed in proportions of time spent euthymic (median proportions in follow-up for MP 76.7%, for 
NP 38.7%, and for DP 28.2%, H=18.731, df=2, p<0.001),  in MDEs (median proportions in follow-up 
3.5%, 22.8%, and 30.0%, respectively, H=24.407, df=2, p<0.001), and in manic states (median 
proportions in follow-up 3.7%, 1.1%, and 1.0%, respectively, H=7.373, df=2, p=0.025). In subgroup 
analyses, these differences remained statistically significant within the BD I group (N=80, p-values 
0.005, 0.002, and 0.037, respectively), but among the BD II patients (N=95) only the difference in 
time spent in MDEs (p=0.008).  
In post hoc pairwise Kruskall-Wallis comparisons, the MP group spent more time in euthymia than 
the DP group (p<0.000) or NP group (p=0.001), less time in MDEs than the DP group (p<0.000) or 
NP group (p<0.000), and more time in manic states than the DP group (p=0.019) or NP group 
(p=0.008).  
In Poisson regression models, adjusted for BD type, age, and gender, the DP group had smaller 
total number of phases in follow-up than the NP group (B=-0.223, p=0.005) and less MDEs than 
the NP group (B=-0.250, p=0.022).The MP group had more manic phases than the NP group 
(B=0.519, p<0.001) or DP group (B=0.747, p<0.001), less MDEs than the NP group (B=-0.615, 
p<0.001) or DP group (B=-0.365, p=0.049), and less mixed phases than the NP group (B=-0.779, 
p=0.025). 
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Stability of polarity types in follow-up 
When predominant polarity was defined using the number of phases from the time of the first 
illness phase to baseline (median time 12.1 years) versus the number of phases in the 5-year 
prospective follow-up (median follow-up time 5.3 years, N=145), predominant polarity remained 
the same for 42.7% of the cohort (Table 4). The polychoric correlation for the stability was 0.407, 
meaning that a latent polarity continuum explained 0.4072 × 100% ≈ 16.6% of the follow-up 
polarity continuum. When the patients with less than three phases in follow-up were excluded, 
the predominant polarity remained the same for 47% of the patients in the follow-up. However, 
when comparing the predominant polarity defined with the count of phases before baseline with 
that of the whole illness duration from the first illness phase to the end of the 5-year follow up 
(excluding the patients with no phases in follow-up) the stability increased to 75.9%, or to 78.1% 
(excluding also those with less than three phases before baseline).  
 
Impact of predominant polarity on suicide attempts in follow-up 
The incidences of suicide attempts in different polarity groups in the 5-year follow-up are 
presented in Figure 2. The overall incidence rate per 1000 patient-years was 126 (95% CI 102-155). 
The incidence for the MP group was the lowest, 32/1000 person-years (95% CI 12-86), followed by 
the incidence of 127/1000 person-years for the NP group (95% CI 94-172) and 170/1000 person-
years for the DP group (95% CI 126-228).  
In Poisson regression analysis, patients in the MP group had significantly fewer suicide attempts 
than patients in either the DP group (B=-1.660, p=0.001) or the NP group (B=-1.366, p=0.009). 
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These results remained but were attenuated when age, BD type, gender, and time spent in high-
risk states for suicide attempts (MDE and mixed states) were controlled.  
 
Impact of predominant polarity on comorbidity and other clinical variables 
The results of the univariate multinomial regression model are presented in Table 3. The MP 
group had lower prevalence of lifetime comorbid anxiety disorders, more often (hypo)manic first 
phase of the illness, and less frequently MDE as the first phase of the illness relative to the DP 
group in the adjusted model. In the non-adjusted model, more frequent occurrence of lifetime 
psychotic symptoms was associated with the MP group, and more frequent occurrence of 
comorbid lifetime substance abuse with the NP group.  
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Discussion  
In this prospective study, we followed a regionally representative cohort of secondary care BD I 
and II patients for five years. Based on retrospective information, about one-sixth of the patients 
had a predominantly manic (MP), one-half intermediate (no polarity, NP), and one-third a 
depressive polarity (DP) pattern. While there were significant differences in time spent ill during 
follow-up between the polarity groups, consistency of their categorical classification was less 
impressive. However, the incidence of suicide attempts in follow-up was over fivefold in the 
depressive polarity group relative to the manic polarity group. The groups were found to differ 
expectedly in terms of lifetime comorbidity with anxiety disorder, but not substance use. Overall, 
including the intermediate no polarity group, the analyses revealed that the manic predominant 
polarity group had a better prognosis than the other two groups, which resembled each other 
more.  
The major strength of this study is the prospective life-chart methodology, which allowed us to 
define the length and timing of different mood episodes and subthreshold symptoms, as well as 
the occurrence and timing of suicide attempts in follow-up. This study design also allowed 
accounting for the patients’ different follow-up times of and to examining the predictive validity 
of predominant polarity at the level of time spent in varying illness states. The epidemiologically 
representative secondary level psychiatric care sample includes in- and outpatients with BD I and 
BD II in all possible index episodes. Patients without a clinical diagnosis of BD were also included 
by first screening with MDQ (Hirschfeld et al., 2000) and then diagnosing by SCID-I/P (First et al., 
2002). Furthermore, their comorbid disorders were carefully examined by using SCID-I/P (First et 
al., 2002) and SCID-II interviews (First et al., 1997). What constitutes a long-term follow-up is a 
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relative matter, but five years seems to be long enough e.g. to eliminate the effect of index 
episode on important outcomes such as time ill (Mantere et al., 2008; Pallaskorpi et al. 2015).  
Some limitations should be addressed as well. The retrospective counting of former phases at 
baseline is vulnerable to recall bias, but this is a general problem in cross-sectional studies 
defining predominant polarity. Although prospective in nature, the study design allowed only 
retrospective assessments of mood episodes and suicide attempts in interviews at 6 months, 18 
months, and 5 years, which might predispose to underreporting of short and milder illness 
phases. However, information in interviews was collected from multiple sources, including patient 
records and observations of personnel and relatives. The sample size is moderate and despite 
massive efforts to reach all original participants, the loss of patients by the 5-year interview could 
not be totally avoided, but only 14/191 patients (7.3%) missed all three follow-up interviews. The 
moderate sample size might limit the statistical power in some analyses. The cohort also included 
patients with very recent onset of illness, and some patients had no or very few prospective illness 
phases. Assignment of dominant polarity may necessitate a sufficient number of illness phases in 
order not to become spurious. Finally, this study was naturalistic, and the influence of the 
treatment could not be controlled.  
 We found that patients in different predominant polarity groups differed in their clinical 
outcome. Patients in the MP group had better outcome than those in the other two groups in 
many respects. In accordance with a retrospective study of Vidal-Rubio et al. (Vidal-Rubio et al., 
2018), we found the MP group to spent more time in euthymia. They also spent less time in MDEs 
and more in manic states. However, probably since there are multiple indications for 
hospitalization among BD patients, contrary to study of Belizario et al. (Belizario et al., 2018), this 
did not lead to higher frequency of hospitalizations. In specific subgroup analyses, the differences 
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in time ill were significant in the BD I group, but for the BD II group the findings persisted only for 
the time spent in MDEs, almost reaching significance also for the time spent euthymic. In terms of 
numbers of illness phases, the MP group had a smaller number of MDEs and more manic phases 
in follow-up than the other groups. This is in accordance with previous findings in the 10-year 
follow-up of Gonzalez-Pinto et al. (Gonzalez-Pinto et al., 2010) and in the 7-year follow-up of 
Belizario et al. (Belizario et al., 2018). However, in the total number of phases during the follow-up 
we found differences only between the DP group and the NP group. The intermediate NP group 
had more illness phases overall, as well as more MDEs specifically, but no difference between 
these two groups was observed in time spent ill. Contrary to the study of Vieta et al. (Vieta et al., 
2009), we found at baseline no difference in the occurrence of rapid cycling between the groups 
(Table 1). Our finding of the MP group having more lifetime psychotic symptoms (in the non-
adjusted model) may be due to psychotic mania or psychotic depression, but is concordant with 
previous studies showing that MP is associated with a first illness episode with psychotic features 
(Popovic et al., 2014; Baldessarini and Undurraga et al.2012), lifetime psychotic symptoms 
(Popovic et al., 2014) and higher number of episodes with psychotic symptoms in follow-up 
(Belizario et al., 2018) . The effects of treatment were not controlled and there are probably more 
effective treatment options for manic than depressive states (Yatham et al., 2018; Vieta et al., 
2018).Thus, the treatment effects might have contributed to the more favorable course of the MP 
group. However, this merely reflects clinical reality. 
If classification of predominant polarity is to be clinically useful, it must be reliable and have 
predictive validity. We found that predominant polarity predicted group-level differences in times 
ill, but consistency between retrospective and prospective polarity assignment was lower than in 
the 7-year follow-up of Belizario et al (Belizario et al., 2018). It improved slightly by excluding 
cases with less than three phases during follow-up (from 43% to 47%). However, classification of 
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predominant polarity remained the same in 76% of cases when those assigned at baseline were 
compared with those at the end of follow-up, when the whole illness history up to the end of the 
follow-up was observed. These findings indicate that validity of the classification is strongly 
influenced by the time frame used, and the evaluation of predominant polarity can be reliably 
undertaken only after some illness phases have passed. This is problematic since for clinical 
purposes such evaluations should be done as early as possible to prevent chronicity. In accord 
with many previous studies (Colom et al., 2006; Daban et al., 2006; Rosa et al., 2008; Forty et al., 
2009; Mazzarini et al., 2009; Baldessarini and Undurraga et al.2012; Popovic et al., 2014; Azorin et 
al., 2015; Janiri et al., 2017), we found an association between the predominant polarity and the 
polarity of the first illness episode, which might be a useful predictor early in the course of bipolar 
illness. The optimal time-point for evaluation of predominant polarity remains to be elucidated by 
future studies.   
Predominant polarity predicted several-fold differences in incidence of suicide attempts during 
the follow-up, which is both an important aspect of predictive validity and important clinically. 
Although we did not find an association between retrospective lifetime history of suicide 
attempts and predominant polarity, the finding of the MP group having less suicide attempts in 
follow-up is in line with many earlier studies (Colom et al., 2006; Gonzalez-Pinto et al., 2010; 
Popovic et al., 2014) but contrary to a recent prospective study, which found higher number of 
suicide attempts among the MP group (Belizario et al., 2018). We found the incidence to exist 
along a continuum from the MP group to the DP group, with the NP group situated between 
these two groups (Figure 1). The MP group had less suicide attempts than the other two groups, 
which did not differ significantly from each other. The impact of the mixed states on suicidality is 
of interest; Baldessarini et al. (Baldessarini and Undurraga et al.2012) found that when mixed 
states were combined with the depressive category, the association of the DP group with suicide 
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attempts almost doubled. This is in accordance with the vast differences discovered in the 
incidences of suicide attempts during different illness states, with mixed phases having the 
highest risk (Pallaskorpi et al., 2017). We classified the mixed states (see Definition 2, Table 1) in 
accordance with the DSM-5 (American Psychiatric Association, 2013), which influences 
comparisons of some outcome measures with previous studies. However, our key findings were 
influenced only marginally by sensitivity analyses that excluded mixed phases.  
The intermediate NP group has received scant attention in earlier research (Belizario et al., 2018). 
The definition of predominant polarity considers only the ratio of the illness states, not the 
number of episodes. So, in theory, patients in this intermediate group could suffer from a more 
serious course of illness with regard to factors such as number of episodes, rapid cycling, time ill, 
and occurrence of comorbid disorders. According to our findings, the NP group resembles the DP 
group in many respects. However, the NP group had more lifetime comorbid substance abuse 
disorders than the DP group in the non-adjusted model and they also were more often inpatients 
at intake. We found no difference in time spent in manic states, MDEs, or euthymia during the 
follow-up between these two groups. Nor was there a difference in the total number of phases 
before baseline when the duration of illness history was adjusted, but in the follow-up the NP 
group had more MDEs and more phases altogether than the DP group. In clinical practice, MP 
might be a more powerful predictor of (better) illness course than DP, which appears only partly 
distinguishable from the NP group. Patients with depressive illness course need more prompt 
monitoring for suicidality, the presence of mixed features highlighting this need further and also 
having potential prognostic and therapeutic implications (Pacchiarotti et al., 2011; Pacchiarotti et 
al., 2013; Popovic et al., 2014).  
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We found predominant polarity to be associated with psychiatric comorbidity. Only a few studies, 
mostly with negative findings exist on the occurrence of comorbid disorders related to 
predominant polarity. Our finding of the MP group having lower lifetime prevalence of comorbid 
anxiety disorders than the DP group is consistent with that of Azorin et al. (Azorin et al., 2015), a 
recent meta-analysis (Garcia-Jimenez et al., 2017) and our previous finding of strong covariation 
of depression and anxiety over the course of BD (Mantere et al., 2010). Some of the earlier studies 
combined the anxiety disorders and substance use disorders as “Axis I disorders”, which may 
explain their negative results, since these two disorders may have contradictory associations with 
predominant polarity. However, the results concerning substance use disorders (SUDs) and the 
predominant polarity are conflicting. The SUDs and drug abuse before the first illness episode of 
BD have been associated with MP (Colom et al., 2006; Popovic et al., 2014; Garcia-Jimenez et al., 
2017), and our previous study indicates that SUDs seem to covary strongly with manic symptoms 
along illness course (Mantere et al., 2010). In contrast, Janiri et al. (Janiri et al., 2017) noted that 
BD patients without SUDs more often had MP, while BD patients with alcohol use disorder or 
polysubstance use more often had DP. We observed no difference in the occurrence of lifetime 
comorbid SUDs between the MP and DP groups. Long-term studies that take into account also 
the influence of current mood state are needed to clarify the relationship between SUDs and 
predominant polarity.  
Conclusion 
In this long-term study, we found that the classification of BD I and BD II in- and outpatients 
according to their predominant polarity has predictive validity, but in a significant minority of 
patients their classification status may change. Patients with manic predominant polarity may 
represent a more distinct subgroup, having a better prognosis in terms of time euthymic, 
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incidence of suicide attempts, and prevalence of comorbid anxiety disorders, but may more often 
suffer from psychotic symptoms. In contrast, the depressive and intermediate no predominant 
polarity groups may be only partly distinguishable from each other.  
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Table 1. Proportions of Predominant Polarity Depending on the Definition for the 188 
Patients in the Jorvi Bipolar Study. 
 
    
ALL  
(N=188) 
BD I  
(N=88) 
BD II 
(N=100)    
    
N (%) 
 
N (%) 
 
N (%) 
 
     
Definition 1:       
WITHOUT MIXED PHASES (mixed phases included in the total sum of phases) 
  
     
Manic polarity 
  
21 (11%) 
 
13 (15%) 
 
8 (8%) 
 
     
Depressive polarity 
  
44 (23%) 
 
13 (15%) 
 
31 (31%) 
 
     
No polarity dominance 
 
123 (65%) 
 
62 (70%)  
 
61 (61%) 
 
     
          
     
Definition 2:      
MIXED PHASES (BD Ia) SUMMED WITH MANIC PHASES AND  
    
     
DEPRESSIVE MIXED PHASES (BD II) SUMMED WITH DEPRESSIVE PHASES  
  
     
Manic polarity 
  
30 (16%) 
 
22 (25%) 
 
8 (8%) 
 
     
Depressive polarity 
  
68 (36%) 
 
13 (15%)  
 
55 (55%) 
 
     
No polarity dominance  
 
90  (48%) 
 
53 (60%)   
 
37 (37%) 
 
     
 
 
a mixed and depressive mixed not specified for BD I patients 
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Table 2. Baseline Sociodemographic and Clinical Characteristics of 188 BD Patients With 
Manic and Depressive Predominant Polarity and Without Polarity Dominance in the Jorvi 
Bipolar Study.  
 
Variable Manic  polarity 
N=30 
 
No polarity 
dominance 
N=90 
Depressive 
polarity 
N=68 
Sig. 
N % N % N % χ2 p 
Gender       3.190 0.203 
Male 15 50.0 47 52.2 26 38.2   
Female 15 50.0 43 47.8 42 61.8   
Marital status       0.504 0.777 
Not cohabiting 17 56.7 54 60.0 37 54.4   
Married or 
cohabiting 
13 43.3 36 40.0 31 45.6   
Education       3.360 0.186 
Professional 
education 
20 66.7 58 64.4 35 51.5   
No professional 
education 
10 33.3 32 35.6 33 48.5   
Work Status       3.818 0.148 
Working 9 30.0 24 26.7 28 41.2   
Not working 21 70.0 66 73.3 40 58.8   
BD type       34.69
4 
<0.00
1 
                           I 22 73.3 53 58.9 13 19.1   
                           II    8 26.7 37 41.1 55 80.9   
Depressive index phase  9 30.0 54 60.0 42 61.8 9.723 0.008 
First phase of illness       35.45
1 
<0.00
1 
Mania or 
hypomania 
17 56.7 15 16.9 9 13.4   
MDE 4 13.3 48 53.9 44 65.7   
Mixed phase 2 6.7 1 1.1 1 1.5   
Polyphasic 
episode 
7 23.3 25 28.1 13 19.4   
Rapid cycling 6 20.0 32 35.6 22 32.4 2.515 0.284 
Psychotic symptoms, lifetime 21 70.0 48 53.3 27 39.7 8.001 0.018 
Suicide attempts, lifetime 13 43.3 50 55.6 34   50.0 1.454 0.483 
Any anxiety disorder, lifetime 10 33.3 45 50.0 44 64.7 8.708 0.013 
Any substance abuse, lifetime 12 40.0 55 61.1 29 42.6 7.033 0.030 
Cluster A personality disorder 5 16.7 10 11.1 4 5.9 2.857 0.240 
Cluster B personality disorder 7 23.3 30 33.3 16 23.5 2.255 0.324 
Cluster C personality disorder 5 16.7 22 24.4 16 23.5 0.798 0.671 
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Inpatient at intake 9 30.0 40 44.4 14 20.6 10.09
1 
0.006 
         
 Mean SD Mean SD Mean SD   
Age at entry, yearsa 39.3 12.8 38.2 11.0 36.1 13.2  0.374 
No. of phases, lifetimea 12.5 11.5 17.2 17.0 11.5 12.1  0.776 
aKruskall-Wallis test  
MDE=major depressive episode 
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Table 3. Stability of the Polarity Types of 145 Patients When Comparing the Time Up to 
Baseline and the 5-Year Follow-up Period in the Jorvi Bipolar Study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aPatients with no phases in follow-up excluded 
 
MP = manic predominant polarity 
DP = depressive predominant polarity 
NP = no predominant polarity 
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Table 4. Multinomial Univariate Logistic Regression of Baseline Lifetime Comorbid Disorders and Clinical Variables for Polarity Groups 
in the Jorvi Bipolar Study. Depressive Polarity Group Is Set As the Reference Category.  
 
 Non-adjusted model  Adjusted model* 
 No polarity  Manic polarity No polarity Manic polarity 
Comorbid disorder/ 
clinical variable 
OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
Any anxiety disorder, 
lifetime 
0.545 0.286-1.041 0.066 0.273 0.110-0.676 0.005 0.654 0.324-1.319 0.236 0.334 0.125-0.888 0.028 
Any substance abuse, 
lifetime 
2.113 1.113-4.011 0.022 0.897 0.374-2.149 0.807 1.585 0.776-3.234 0.206 0.579 0.213-1.573 0.284 
Cluster A personality 
disorder 
2.000 0.599-6.675 0.260 3.200 0.794-
12.895 
0.102 1.937 0.534-7.031 0.315 3.314 0.719-15.272 0.124 
Cluster B personality 
disorder 
1.625 0.798-3.310 0.181 0.989 0.359-2.729 0.983 1.679 0.766-3.681 0.196 0.986 0.327-2.971 0.980 
Cluster C personality 
disorder  
1.051 0.503-2.200 0.894 0.650 0.214-1.976 0.448 1.213 0.541-2.723 0.639 0.771 0.234-2.539 0.668 
Psychotic symptoms, 
lifetime 
1.317 0.957-1.813 0.091 1.882 1.189-2.891 0.007 1.045 0.727-1.502 0.812 1.376 0.827-2.290 0.220 
First phase MDE 0.612 0.318-1.177 0.141 0.080 0.025-0.258 <0.001 0.589 0.280-1.240 0.163 0.075 0.022-0.261 <0.001 
First phase (hypo)manic 1.306 0.534-3.197 0.558 8.427 3.078-
23.074 
<0.001 1.232 0.469-3.235 0.672 7.829 2.587-23.689 <0.001 
Rapid cycling, baseline 1.074 0.770-1.499 0.674 0.723 0.432-1.209 0.217 1.115 0.770-1.616 0.563 0.738 0.421-1.296 0.290 
*adjusted for age, gender, and BD type 
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*Remaining states include hypomanic symptoms, cyclothymia, mood episodes caused by substance use, and 
not possible to classify. MP=manic polarity, NP=no polarity, DP= depressive polarity 
 
Figure 1. Time Ill for the Different Polarity Groups in the Jorvi Bipolar Study Five-Year Follow-up. 
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Figure 2. Incidence of Suicide Attempts in the Jorvi Bipolar Study 5-year Follow-up for Different 
Polarity Groups.  
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